Roll compaction granulation of a controlled-release matrix tablet formulation containing HPMC: Effect of process scale-up on robustness of tablets, tablet stability and predicted in vivo performance
Sheskey, P.; Pacholke, K.; Sackett, G.; Maher, L.; Polli, J.
Pharmaceutical Technology 24(11): 30-52
2000
ISSN/ISBN: 0147-8087
Accession: 077660110
PDF emailed within 1 workday: $29.90
Related References
Sheskey, P.J.; Hendren, J. 1999: The effects of roll compaction equipment variables, granulation technique, and HPMC polymer level on a controlled-release matrix model drug formulation Pharmaceutical Technology 23(3): 90-106Sheskey, P.J.; Davidson, J.E. 1996: Initial evaluation of selected variables affecting the robustness of matrix controlled release tablet formulations containing HPMC polymers Pharmaceutical Research (New York) 13(9 Suppl): S310
Kohya, S.; Mills, A.; Smith, J.S.; Macrae, R.J. 1999: Assessment of binary wet granulation of a controlled release hydrophilic matrix tablet formulation Journal of Pharmacy and Pharmacology 51(Suppl ): 294
Talukdar, M.M.; Van den Mooter, G.; Augustijns, P.; Tjandramaga, T.; Verbeke, N.; Kinget, R. 1998: In vivo evaluation of xanthan gum as a potential excipient for oral controlled-release matrix tablet formulation International Journal of Pharmaceutics 169(1): 105-113
Talukdar, M.M.; Van Den Mooter, G.; Augustijns, P.; Tjandra Maga, T.; Verbeke, N.; Kinget, R. 1998: In vivo evaluation of xanthan gum as a potential excipient for oral controlled-release matrix tablet formulation International Journal Of Pharmaceutics (amsterdam). 169(1): 105-113, E 30
Khan, R.; Ashraf, M.S.; Afzal, M.; Kazmi, I.; Jahangir, M.A.; Singh, R.; Chandra, R.; Anwar, F. 2014: Formulation and evaluation of sustained release matrix tablet of rabeprazole using wet granulation technique Journal of Pharmacy and Bioallied Sciences 6(3): 180-184
Gamlen, M.John.Desmond.; Martini, L.G.; Al Obaidy, K.G. 2015: Effect of repeated compaction of tablets on tablet properties and work of compaction using an instrumented laboratory tablet press Drug Development and Industrial Pharmacy 41(1): 163-169
Sheskey, P.J.; Williams, D.M. 1996: Comparison of low-shear and high-shear wet granulation techniques and the influence of percent water addition in the preparation of a controlled-release matrix tablet containing HPMC and a high-dose, highly water-soluble drug Pharmaceutical Technology 20(3): 80-92
Trigger, D.J.; Davies, P.J.; Parker, M.S. 1988: The relationship of theophylline release with tablet surface area and aspect ratio from a new matrix tablet formulation Drug Development and Industrial Pharmacy 14(15-17): 2377-2386
Košir, D.; Ojsteršek, T.; Vrečer, F. 2018: Does the performance of wet granulation and tablet hardness affect the drug dissolution profile of carvedilol in matrix tablets? Drug Development and Industrial Pharmacy 44(9): 1543-1550
Prajapati, S.T.; Patel, A.N.; Patel, C.N. 2011: Formulation and evaluation of controlled-release tablet of zolpidem tartrate by melt granulation technique Isrn Pharmaceutics 2011: 208394
Wu, B.; Deng, D.; Lu, Y.; Wu, W. 2008: Biphasic release of indomethacin from HPMC/pectin/calcium matrix tablet: II. Influencing variables, stability and pharmacokinetics in dogs European Journal of Pharmaceutics and Biopharmaceutics: Official Journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik E.V 69(1): 294-302
Xu, G; Sunada, H; Zhang, R 1997: Indomethacin Controlled Release Matrix Tablet Prepared by Wet Granulation Procedure Chemical and Pharmaceutical Bulletin 45(1): 214-216
Herting, M.G.; Kleinebudde, P. 2007: Roll compaction/dry granulation: effect of raw material particle size on granule and tablet properties International Journal of Pharmaceutics 338(1-2): 110-118
Kala, H.; Danz, R.; Bekemeier, H.; Moldenhauer, H. 1980: In vivo testing of a 3-hydroxymethylpyridine hydrogen tartrate matrix tablet. Part 2: Comparison between the in vivo drug release from the matrix form and that from Radecol-tablets Die Pharmazie 35(4): 216-221
Hirun, N.; Kraisit, P. 2022: Drug-Polymers Composite Matrix Tablets: Effect of Hydroxypropyl Methylcellulose (HPMC) K-Series on Porosity, Compatibility, and Release Behavior of the Tablet Containing a BCS Class i Drug Polymers 14(16)
Huang, Y-Tyng.; Tsai, T-Rong.; Cheng, C-Jen.; Cham, T-Ming.; Lai, T-Fwu.; Chuo, W-Ho. 2007: Formulation design of an HPMC-based sustained release tablet for pyridostigmine bromide as a highly hygroscopic model drug and its in vivo/in vitro dissolution properties Drug Development and Industrial Pharmacy 33(11): 1183-1191
Muhuri, G.; Alemayehu, B.; Anucha, T.; Chau, S.; Ekpo, P.; Eradiri, O.; Hassan, A.; Ly, C.; Malaiyandi, P.; Odidi, A.; Odidi, I.; Siwicki, J.; Wang, Y. 1997: Effect of tablet hardness on in vitro release rate of drugs from controlled-release matrix tablets The role of release mechanism Pharmaceutical Research (New York) 14(11 Suppl): S11
Al-Hanbali, O.A.; Hamed, R.; Arafat, M.; Bakkour, Y.; Al-Matubsi, H.; Mansour, R.; Al-Bataineh, Y.; Aldhoun, M.; Sarfraz, M.; Dardas, A.K.Y. 2018: Formulation and evaluation of diclofenac controlled release matrix tablets made of HPMC and Poloxamer 188 polymer: An assessment on mechanism of drug release Pakistan Journal of Pharmaceutical Sciences 31(1 Suppl.): 345-351
Nakade, S.; Komaba, J.; Ohno, T.; Kitagawa, J.; Furukawa, K.; Miyata, Y. 2008: Bioequivalence study of two limaprost alfadex 5 microg tablets in healthy subjects: moisture-resistant tablet (dextran formulation) versus standard tablet (lactose formulation) International Journal of Clinical Pharmacology and Therapeutics 46(1): 42-47